Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
38673 POSTS 0 COMMENTS

Preoperative SGLT2 Inhibitor Users Have Increased Risk for Postoperative Euglycemic Ketoacidosis

0

Risk for postoperative eKA slightly increased; lower risks seen for perioperative acute kidney injury and 30-day mortality

Hearing Loss Intervention Reduces Social Isolation in Seniors

0

Reduction in social network size smaller with hearing intervention versus health education control

General Practitioners Face Barriers to Treating Patients’ Sexual Problems

0

Personal attitudes, practice patterns, and lack of knowledge are reported barriers

No Causal Link Seen Between Stimulant Prescription, Psychotic Experience

0

No evidence observed for causal effect of stimulant prescription on subsequent psychotic experiences when applying doubly robust estimation

President Signs Executive Order to Lower Some Drug Costs

0

Order expected to affect specific medications covered under Medicare that are administered in a health care setting

Trump Administration Cuts Funding for Life-Saving Baby Heart Device

0
By I. Edwards HealthDay Reporter MONDAY, May 12, 2025 (HealthDay News) — A Cornell University project to save babies born with serious heart defects has...

FDA Approves At-Home Cervical Cancer Test for Women Ages 25 to 65

0
By I. Edwards HealthDay Reporter MONDAY, May 12, 2025 (HealthDay News) — Women now have a new way to check their risk for cervical cancer...

GLP-1 Receptor Agonists Reduce Alcohol Intake in Patients Treated for Obesity

0

Reductions in alcohol intake noted in high and low consumers; no significant difference seen in percentage reductions for men and women

BCG Revaccination Does Not Provide Protection From Sustained Mycobacterium Tuberculosis Infection

0

Adverse events occurred more often in the BCG revaccination group, and most were due to injection-site reactions

Adding Bevacizumab to Chemo Beneficial in High-Risk Ovarian Cancer

0

Real-world benefit seen with addition of bevacizumab to first-line chemotherapy for patients with high‐risk prognostic factors